Quince Therapeutics, Inc. - Common Stock, par value $0.001 per share (QNCX)

Q: What does CUSIP 22053A107 represent in this 13F holders report?

CUSIP 22053A107 is the security identifier for QNCX - Quince Therapeutics, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held QNCX - Quince Therapeutics, Inc. - Common Stock, par value $0.001 per share in Q4 2025?

67 institutional investors reported QNCX - Quince Therapeutics, Inc. - Common Stock, par value $0.001 per share for Q4 2025. Use the holders table for investor-level position and value details.

CUSIP: 22053A107

Q4 2025 13F Holders as of 31 Dec 2025

Security type / class: Equity / Common Stock, par value $0.001 per share
Total 13F shares: 20,143,303
Total 13F value: $67,479,982
Share change: +8,350,640
Put/Call ratio: 258%
SEC-reported price per share: $3.35
Number of holders: 67
Value change: +$28,429,772
Number of buys: 46
Number of sells: 9
Shares outstanding: 60,216,782

Security key

22053A107

Report period

Q4 2025

Institutions

Top holders

QNCX full security history Ownership snapshot Full 13F holder table Newer quarter: Q2 2026 Quince Therapeutics, Inc. SEC filings Quince Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 22053A107

Newer quarter: Q2 2026

Recent filing periods:

Q2 2026

Ownership snapshot

Top reported holders of QNCX - Quince Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Sofinnova Partners SAS

Disclosed value leader

Nantahala Capital Managem...

Comparable rows

15/15

Latest evidence

30 Sep 2025

13D/G 13F Lead comparable stake: 2.7% 13D/G row: Sofinnova Partners SAS Showing 1-6 of 15 holder rows.

Quick read

Sofinnova Partners SAS leads the comparable SEC ownership view at 2.7%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Sofinnova Partners SAS's linked filing trail.

Comparable ownership Top 5

Sofinnova Partners SAS 2.7%

Nantahala Capital Management, LLC 5.1%

VANGUARD GROUP INC 2.9%

MILLENNIUM MANAGEMENT LLC 2.3%

IEQ CAPITAL, LLC 1.6%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Sofinnova Partners SAS	13D/G Sofinnova Capital VIII 13D/G	2.7%	$1,185,734 1,197,711 shares	-$1,188,000	31 Mar 2025
Nantahala Capital Management, LLC	13F Company 13F	5.1%	$5,010,178 3,073,729 shares	—	30 Sep 2025
VANGUARD GROUP INC	13F Company 13F	2.9%	$2,874,320 1,763,387 shares	—	30 Sep 2025
MILLENNIUM MANAGEMENT LLC	13F Company 13F	2.3%	$2,260,445 1,386,776 shares	—	30 Sep 2025
IEQ CAPITAL, LLC	13F Company 13F	1.6%	$1,599,460 981,264 shares	—	30 Sep 2025
ADAR1 Capital Management, LLC	13F Company 13F	1.3%	$1,263,305 775,034 shares	—	30 Sep 2025

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

20,143,303

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders

Q4 2025 holders

Holder diff

Investor	Q3 2025 Shares	Q4 2025 Shares	Share Diff	Share Chg %	Q3 2025 value	Q4 2025 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend